Research Article
Sorafenib-Loaded Long-Circulating Nanoliposomes for Liver Cancer Therapy
Figure 5
The tumor suppression effect in vivo. (a) Monitoring of the fluorescence-labeled nanoliposomes after intravenous injection. (b) The relative volume curve of mice in each treatment group. (c) The photographs of collected tumor tissues. (d) H&E staining of the tumor slices. (e) The weight change curves of mice in each treatment group. The data are presented as the . , .
(a) |
(b) |
(c) |
(d) |
(e) |